Is asymptomatic hemorrhagic transformation really innocuous?

PubWeight™: 1.96‹?› | Rank: Top 2%

🔗 View Article (PMID 22282643)

Published in Neurology on January 25, 2012

Authors

J H Park1, Y Ko, W-J Kim, M S Jang, M H Yang, M-K Han, C-W Oh, S H Park, Jisung Lee, Juneyoung Lee, H-J Bae, P B Gorelick

Author Affiliations

1: Department of Neurology, Dongguk University Gyeongju Hospital, Gyeongju, Korea.

Articles citing this

Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab (2013) 1.41

Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann Neurol (2012) 1.14

Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation. Eur J Neurol (2013) 0.96

RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Ann Neurol (2013) 0.91

Imaging for prediction of functional outcome and assessment of recovery in ischemic stroke. Stroke (2014) 0.85

Use of antithrombotics after hemorrhagic transformation in acute ischemic stroke. PLoS One (2014) 0.82

A Novel Computerized Clinical Decision Support System for Treating Thrombolysis in Patients with Acute Ischemic Stroke. J Stroke (2015) 0.82

Recommendations for preclinical research in hemorrhagic transformation. Transl Stroke Res (2013) 0.81

Lower serum calcium level is associated with hemorrhagic transformation after thrombolysis. Stroke (2015) 0.79

Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke. Neuroradiology (2015) 0.78

Is asymptomatic hemorrhagic transformation really innocuous? Neurology (2012) 0.78

Early statin use in ischemic stroke patients treated with recanalization therapy: retrospective observational study. BMC Neurol (2015) 0.78

Reducing haemorrhagic transformation after thrombolysis for stroke: a strategy utilising minocycline. Stroke Res Treat (2013) 0.76

Postthrombolytic Antiplatelet Use for Patients with Intercerebral Hemorrhage without Extensive Parenchymal Involvement Does Not Worsen Outcome. J Clin Neurol (2015) 0.75

Cardioembolism and Involvement of the Insular Cortex in Patients with Ischemic Stroke. PLoS One (2015) 0.75

Functional Outcome of Hemorrhagic Transformation after Thrombolysis for Ischemic Stroke: A Prospective Study. Cerebrovasc Dis Extra (2015) 0.75

Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. J Stroke (2017) 0.75

Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China. PLoS One (2015) 0.75

Focal T2 and FLAIR hyperintensities within the infarcted area: A suitable marker for patient selection for treatment? PLoS One (2017) 0.75

Articles by these authors

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol (1997) 7.76

Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol (1999) 5.86

Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A (1990) 4.06

Why African Americans may not be participating in clinical trials. J Natl Med Assoc (1996) 3.68

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther (2011) 3.56

Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37

An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med (1999) 3.20

American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65

The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc Natl Acad Sci U S A (1996) 2.32

Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26

CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol (1998) 2.25

Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med (1999) 2.23

Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog (1995) 2.18

Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc (2000) 2.16

Thalamic astasia: inability to stand after unilateral thalamic lesions. Ann Neurol (1988) 2.10

Chromosomal aberrations in neuroblastoma cell lines identified by cross species color banding and chromosome painting. Cancer Genet Cytogenet (2001) 2.09

Race, sex and occlusive cerebrovascular disease: a review. Stroke (1986) 2.05

Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut (2001) 2.05

Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med (1998) 1.98

Cross-resistance of the diamondback moth indicates altered interactions with domain II of Bacillus thuringiensis toxins. Appl Environ Microbiol (1996) 1.95

Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res (1998) 1.95

Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens (2006) 1.94

Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (1999) 1.91

A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction. Mol Cell Probes (2002) 1.91

Prevalence and knowledge of transient ischemic attack among US adults. Neurology (2003) 1.91

Cerebral gangliogliomas: preoperative grading using FDG-PET and 201Tl-SPECT. AJNR Am J Neuroradiol (1998) 1.87

The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther (2007) 1.85

Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.84

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus (2009) 1.81

The fallacy of the levator expansion theory. Plast Reconstr Surg (1999) 1.75

An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease. Am J Psychiatry (1992) 1.69

Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69

Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience. J Natl Med Assoc (1996) 1.68

A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China. Clin Genet (2007) 1.66

The clinical significance of upper gastrointestinal endoscopy in gastrointestinal vasculitis related to scrub typhus. Endoscopy (2000) 1.64

A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol (2013) 1.63

Influenza surveillance in Korea: establishment and first results of an epidemiological and virological surveillance scheme. Epidemiol Infect (2007) 1.60

Endoscopic pituitary surgery: an early experience. Surg Neurol (1997) 1.58

CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology (1999) 1.58

Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol (2008) 1.58

Central neurocytoma: proliferative potential and biological behavior. J Neurosurg (1996) 1.55

Effect of fudosteine on mucin production. Eur Respir J (2008) 1.55

Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology (2000) 1.54

Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation (2011) 1.51

Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol (2001) 1.49

Endoscopic submucosal resection with double ligation technique for treatment of small rectal carcinoid tumors. Endoscopy (2006) 1.49

Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology (2012) 1.48

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48

Effect of central-residue replacements on the helical stability of a monomeric peptide. Biochemistry (1990) 1.47

Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke. J Hypertens (2015) 1.47

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol (2007) 1.46

Radiologists' responses to patients' inquiries about imaging results. A pilot study on opinions of various groups. Invest Radiol (1993) 1.46

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin. Prostate (1997) 1.46

The role of Müller's muscle reconsidered. Plast Reconstr Surg (1998) 1.45

HIV-1 infection by artificial insemination. Lancet (1998) 1.44

Racial differences in the distribution of anterior circulation occlusive disease. Neurology (1984) 1.43

Disconjugate vertical ocular movement in a patient with locked-in syndrome. Br J Ophthalmol (2001) 1.42

Transforming growth factor beta 1 transduced mouse prostate reconstitutions: I. Induction of neuronal phenotypes. Prostate (1997) 1.41

Effects of repeated days of intensified training on muscle glycogen and swimming performance. Med Sci Sports Exerc (1988) 1.41

Drug-administration sequence of target-controlled propofol and remifentanil influences the onset of rocuronium. A double-blind, randomized trial. Acta Anaesthesiol Scand (2012) 1.40

Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem (1995) 1.39

Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation. Cell (1992) 1.39

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis (2007) 1.39

Spinal epidural cavernous hemangioma: MR findings. J Comput Assist Tomogr (2001) 1.38

Usefulness of AgNOR score in differentiating benign from malignant pulmonary aspiration cytology. Acta Cytol (1997) 1.38

The findings of ruptured hepatocellular carcinoma on helical CT. Br J Radiol (2001) 1.37

Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J Biol Chem (1996) 1.36

Caudate infarcts. Arch Neurol (1990) 1.36

Spinal intradural capillary hemangioma: MR findings. AJNR Am J Neuroradiol (2000) 1.35

NMR experiments on aligned samples of membrane proteins. Methods Enzymol (2005) 1.34

N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr (2001) 1.33

Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A (1998) 1.32

Nervous system involvement by metastatic hepatocellular carcinoma. J Neurooncol (1998) 1.32

Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology (1999) 1.31

Axonal dystrophy in the gracile nucleus in congenital biliary atresia and cystic fibrosis (mucoviscidosis): beneficial effect of vitamin E therapy. J Neuropathol Exp Neurol (1980) 1.31

Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma. Ann Oncol (2012) 1.31

The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J Biol Chem (1993) 1.31

Stroke recurrence within 2 years after ischemic infarction. Stroke (1991) 1.30

Transnasal-transsphenoidal endoscopic surgery of the pituitary gland. Laryngoscope (1996) 1.29

Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.29

In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop Relat Res (1996) 1.29

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes. Ann Oncol (2007) 1.28

Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology (2010) 1.27

Identification and characterization of a human cDNA homologous to yeast SKI2. Genomics (1995) 1.27

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia (2009) 1.26

Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J Immunol (2000) 1.26

The origin of submicron polyethylene wear debris in total hip arthroplasty. Clin Orthop Relat Res (1995) 1.25

The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation (2001) 1.24

Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis. Cornea (2001) 1.23

Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism (2007) 1.23

Diabetes epidemics in Korea: reappraise nationwide survey of diabetes "diabetes in Korea 2007". Diabetes Metab J (2013) 1.22

Nonparametric confidence interval estimators for heritability and expected selection response. Genetics (1989) 1.21

Structure and expression of the orphan nuclear receptor SHP gene. J Biol Chem (1998) 1.20

Autopsy recruitment program for African Americans. Alzheimer Dis Assoc Disord (2001) 1.20

Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology (1992) 1.19